Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Deepakraj Gajanana"'
Publikováno v:
Cureus.
Autor:
Itsik Ben-Dor, Cheng Zhang, Jaffar M. Khan, Toby Rogers, Ron Waksman, Yuefeng Chen, Lowell F. Satler, Deepakraj Gajanana, Nauman Khalid, Evan Shlofmitz, Anees Musallam, William S. Weintraub, Paul Kolm, Rebecca Torguson, Micaela Iantorno
Publikováno v:
The American Journal of Cardiology. 125:1631-1637
Patients undergoing percutaneous coronary intervention (PCI) often have high-bleeding-risk (HBR) factors. Dual antiplatelet therapy (DAPT) further increases this risk of bleeding. We sought to compare clinical outcomes according to presence or absenc
Autor:
Yuefeng Chen, Ron Waksman, Evan Shlofmitz, Nauman Khalid, Paul Kolm, Rebecca Torguson, William S. Weintraub, Toby Rogers, Micaela Iantorno, Deepakraj Gajanana
Publikováno v:
The American Journal of Cardiology. 125:165-168
It is estimated that each year in the United States780,000 persons will experience an acute coronary syndrome. Approximately 70% of these will have non-ST-elevation myocardial infarction (NSTEMI). Optimal timing of angiography in NSTEMI is a matter o
Autor:
Itsik Ben-Dor, Evan Shlofmitz, Alexandre H. Kajita, Nauman Khalid, Rebecca Torguson, Deepakraj Gajanana, Jaffar M. Khan, Toby Rogers, Yuefeng Chen, Lowell F. Satler, Hayder Hashim, Micaela Iantorno, Anees Musallam, William S. Weintraub, Ron Waksman, Paul Kolm
Publikováno v:
The American Journal of Cardiology. 124:1349-1356
Percutaneous coronary intervention (PCI) has evolved dramatically, along with patient complexity. We studied trends in in-hospital mortality with changes in patient complexity over the last decade stratified by clinical presentation. The study popula
Autor:
Micaela Iantorno, Rebecca Torguson, Anees Musallam, Evan Shlofmitz, Nelson L. Bernardo, Yuefeng Chen, Toby Rogers, Nauman Khalid, Ron Waksman, Hayder Hashim, Deepakraj Gajanana, Jaffar M. Khan
Publikováno v:
Cardiovascular Revascularization Medicine. 20:503-506
Background/purpose Right ventricular (RV) mechanical circulatory support remains an important adjunctive therapy for RV failure refractory to medical therapy. Impella RP (Abiomed, Danvers, MA) is approved for providing temporary RV support for patien
Autor:
Toby Rogers, Kyle Buchanan, Solomon Beyene, Echo Brathwaite, Gebremedhin D. Melaku, Yael F. Meirovich, Kazuhiro Dan, Paul Kolm, Deepakraj Gajanana, Yuichi Ozaki, Rebecca Torguson, Micaela Iantorno, Aaphtaab Dheendsa, Hector M. Garcia-Garcia, Alexandre Hideo-Kajita, Ron Waksman
Publikováno v:
The American Journal of Cardiology. 123:1228-1238
Percutaneous coronary intervention (PCI) in patients with angiographic evidence of intracoronary thrombus is associated with in-hospital and 30-day adverse clinical outcomes. Cangrelor, a direct, rapid-onset acting intravenous P2Y12 receptor inhibito
Autor:
William O. Suddath, Toby Rogers, Lowell F. Satler, Itsik Ben-Dor, Jiaxiang Gai, Paul Kolm, Ron Waksman, Kyle Buchanan, Rebecca Torguson, Micaela Iantorno, Deepakraj Gajanana
Publikováno v:
Cardiovascular Revascularization Medicine. 20:11-15
BACKGROUND/PURPOSE Appropriate patient selection for mechanical circulatory support following percutaneous coronary intervention (PCI) remains a challenge. This study aims to evaluate the role of coronary perfusion pressure and other left ventricular
Autor:
Vinod H. Thourani, Rebecca Torguson, Kyle Buchanan, Toby Rogers, Augusto D. Pichard, William S. Weintraub, Petros Okubagzi, Paul Kolm, Itsik Ben-Dor, Lowell F. Satler, Ron Waksman, Deepakraj Gajanana, Micaela Iantorno
Publikováno v:
Cardiovascular Revascularization Medicine. 19:912-916
BACKGROUND/PURPOSE Dual antiplatelet therapy (DAPT) varies after placement of drug-eluting stents (DES) in patients presenting with acute coronary syndromes (ACS). Our aim was to study patient characteristics and predictors of switching, in-hospital
Autor:
Itsik Ben-Dor, Petros Okubagzi, Kyle Buchanan, William S. Weintraub, Vinod H. Thourani, Toby Rogers, Deepakraj Gajanana, Lowell F. Satler, Micaela Iantorno, Ron Waksman, Augusto D. Pichard, Rebecca Torguson
Publikováno v:
The American Journal of Cardiology. 122:1536-1540
There is scarcity of evidence regarding antiplatelet and anticoagulant therapy in patients with prosthetic valves undergoing percutaneous coronary intervention (PCI). Our goal was to compare clinical outcomes between patients with mechanical or biopr
Publikováno v:
Cardiovascular Revascularization Medicine. 19:2-6